Cefuroxime Axetil Tablet, Film Coated
Product Images NDC 57237-059

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cefuroxime Axetil (NDC 57237-059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (250 mg (20 Tablets Bottle))

Rising Cefuroxime Axetil tablets contain 250 mg of cefuroxime for treatment of bacterial infections. The package insert includes information on dosage and administration. The tablets are distributed by Rising Health, LLC in Saddle Brook, NJ and manufactured in India. The tablets should be stored at 20°C to 25°C and kept away from children. No information is provided on the over printing zone.*

FDA Label Image

Package Label-principal Display Panel (500 mg (20 Tablets Bottle))

Rising® NDC 57237-059-20 is a medicine containing Cefuroxime Axetil USP, which is equivalent to 500mg of cefuroxime, and is distributed by Rising Health, LLC. The package insert includes information regarding dosage and administration. This medicine comes in film-coated tablets and should be stored at temperatures between 20° to 25°C (68° to 77°F), with permitted excursions between 15° to 30°C (59° to 86°F) in controlled room temperature as per the USP standards. The medicine packaging should be securely replaced after each opening and stored out of children's reach. The details about production are recorded in code TS/DRUGS/78/1996.*

FDA Label Image

Chemical Structure (Cefuroxime Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.